Molecule Mind
PrivateLast Round
Series A
Sep 13, 2024
Total Funding Raised
$114.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Molecule Mind is a biotechnology company that develops an AI-driven platform for protein prediction, optimization, and design.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Molecule Mind Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Molecule Mind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 13, 2024 | ||||
| Series A | Jan 21, 2024 | ||||
| Strategic | Feb 20, 2023 | ||||
| Angel | Apr 18, 2022 |
Molecule Mind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series A |
| 联想创投集团 (Lenovo Capital and Incubator Group) | Strategic |
| Baidu Ventures | Angel |
| HongShan | Angel, Strategic |
| Zhongguancun Development Group | Angel |
| Infinity Group | Series A |
| Shenzhen Capital Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Grew 24% QoQ, from 17 to 21 employees.
- Jan 21, 2024
$100M round with participation from Infinity Group and Oriental Fortune Capital.
Molecule Mind Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Molecule Mind's valuation, stock price, and market status.